Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit
- PMID: 17626883
- DOI: 10.1126/science.1135394
Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit
Abstract
Many human cancers involve up-regulation of the phosphoinositide 3-kinase PI3Kalpha, with oncogenic mutations identified in both the p110alpha catalytic and the p85alpha regulatory subunits. We used crystallographic and biochemical approaches to gain insight into activating mutations in two noncatalytic p110alpha domains-the adaptor-binding and the helical domains. A structure of the adaptor-binding domain of p110alpha in a complex with the p85alpha inter-Src homology 2 (inter-SH2) domain shows that oncogenic mutations in the adaptor-binding domain are not at the inter-SH2 interface but in a polar surface patch that is a plausible docking site for other domains in the holo p110/p85 complex. We also examined helical domain mutations and found that the Glu545 to Lys545 (E545K) oncogenic mutant disrupts an inhibitory charge-charge interaction with the p85 N-terminal SH2 domain. These studies extend our understanding of the architecture of PI3Ks and provide insight into how two classes of mutations that cause a gain in function can lead to cancer.
Comment in
-
Biochemistry. PI3K charges ahead.Science. 2007 Jul 13;317(5835):206-7. doi: 10.1126/science.1146073. Science. 2007. PMID: 17626872 No abstract available.
Similar articles
-
Cancer-derived mutations in the regulatory subunit p85alpha of phosphoinositide 3-kinase function through the catalytic subunit p110alpha.Proc Natl Acad Sci U S A. 2010 Aug 31;107(35):15547-52. doi: 10.1073/pnas.1009652107. Epub 2010 Aug 16. Proc Natl Acad Sci U S A. 2010. PMID: 20713702 Free PMC article.
-
Cryo-EM structures of cancer-specific helical and kinase domain mutations of PI3Kα.Proc Natl Acad Sci U S A. 2022 Nov 16;119(46):e2215621119. doi: 10.1073/pnas.2215621119. Epub 2022 Nov 7. Proc Natl Acad Sci U S A. 2022. PMID: 36343266 Free PMC article.
-
The structure of a human p110alpha/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutations.Science. 2007 Dec 14;318(5857):1744-8. doi: 10.1126/science.1150799. Science. 2007. PMID: 18079394
-
Insights into the oncogenic effects of PIK3CA mutations from the structure of p110alpha/p85alpha.Cell Cycle. 2008 May 1;7(9):1151-6. doi: 10.4161/cc.7.9.5817. Epub 2008 Feb 27. Cell Cycle. 2008. PMID: 18418043 Free PMC article. Review.
-
Human tumor mutants in the p110alpha subunit of PI3K.Cell Cycle. 2006 Apr;5(7):675-7. doi: 10.4161/cc.5.7.2605. Epub 2006 Apr 1. Cell Cycle. 2006. PMID: 16627990 Review.
Cited by
-
A functional variant at miR-520a binding site in PIK3CA alters susceptibility to colorectal cancer in a Chinese Han population.Biomed Res Int. 2015;2015:373252. doi: 10.1155/2015/373252. Epub 2015 Mar 5. Biomed Res Int. 2015. PMID: 25834816 Free PMC article.
-
Molecular Pathways: Targeting the PI3K Pathway in Cancer-BET Inhibitors to the Rescue.Clin Cancer Res. 2016 Jun 1;22(11):2605-10. doi: 10.1158/1078-0432.CCR-15-2389. Clin Cancer Res. 2016. PMID: 27250929 Free PMC article. Review.
-
PI3King the right partner: unique interactions and signaling by p110β.Postdoc J. 2015 Jun;3(6):71-87. doi: 10.14304/surya.jpr.v3n6.8. Postdoc J. 2015. PMID: 26140278 Free PMC article.
-
PIK3CA activating mutation in colorectal carcinoma: associations with molecular features and survival.PLoS One. 2013 Jun 13;8(6):e65479. doi: 10.1371/journal.pone.0065479. Print 2013. PLoS One. 2013. PMID: 23785428 Free PMC article.
-
Inability of NS1 protein from an H5N1 influenza virus to activate PI3K/Akt signaling pathway correlates to the enhanced virus replication upon PI3K inhibition.Vet Res. 2012 Apr 24;43(1):36. doi: 10.1186/1297-9716-43-36. Vet Res. 2012. PMID: 22530768 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous
